Steven Kovach

ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.

Keara M. Lane, D. Housman, M. Yaffe, 2006, Cancer research.